Trends of obesity and abdominal obesity in Tehranian adults: a cohort study

BMC Public Health

Table 2 The prevalences of Overweight, Obesity and Abdominal obesity in three phases of TLGS.

Age group (years)	Number	Overweight, %			Obesity, %			Abdominal obesity, %
		Phase I	Phase II	Phase III	Phase I	Phase II	Phase III	Phase I	Phase II	Phase III
*Men*
20-29	266	40.6	55.3	67.3*	10.5	17.6	22.9*	16.1	38.7	53.7*
30-39	459	59.9	69.0	74.3*	15.9	30.7	24.6*	32.6	54.6	61.4*
40-49	369	67.5	74.6	75.1*	15.2	50.3	22.77*	37.6	61.5	65.0*
50-59	319	66.8	69.0	70.8	20.7	47.9	19.7	45.7	62.3	67. 7*
60-69	328	66.8	66.5	66.5	16.8	41.8	16.5	48.4	66.4	69.2*
≥ 70	94	52.1	54.2	48.9	13.8	19.6	12.8	35.1	55.3	57.4*
Total	1835	60.6	66.9	70.1	15.8	37.8	21.1*	36.5	57.2	63.3*
*Women*
20-29	442	41.8	55.7	59.0*	11.8	17.6	18.1*	43.8	54.9	55.2*
30-39	629	69.3	78.3	80.9*	23.2	30.7	33.7*	68.9	80.2	79.8*
40-49	614	82.7	88.3	89.6*	40.4	50.3	49.0*	86.3	92.1	92.5*
50-59	509	84.3	88.2	88.6*	44.4	47.9	52.0*	91.9	94.6	93.9†
60-69	327	81.6	83.1	82.9	38.2	41.8	40.9	92.3	95.7	95.4†
≥ 70	46	73.9	78.3	73.9	17.4	19.6	26.7	89.1	93.4	89.1
Total	2567	72.4	79.4	80.9*	31.3	37.8	38.6*	76.7	83.8	83.6*

TLGS: Tehran Lipid and Glucose Study, Overweight: BMI = 24.9-29.9, Obesity: BMI ≥ 30, Abdominal obesity: WC ≥ 94/80 cm for men/women respectively, * p < 0.001, † p < 0.01 as compared to values in Phase I

ISSN: 1471-2458